Jan de Vries

Co-founder, Board member Tr1X Bio

Jan de Vries is a co-founder and board member of Tr1X Bio, currently based in San Diego County, California, United States.1 He has extensive experience in the biotechnology and pharmaceutical industries, with a career spanning several decades.

Career Highlights

Current Role: Jan de Vries has been serving as a co-founder, consultant, and board observer at Tr1X Bio since May 2023.1

Previous Positions:

Co-founder and CEO of Tr1X from July 2019 to May 20231
Chairman of Cassiopea SpA from July 2015 to May 20231
Chairman and CEO of AIMM Therapeutics from 2012 to 20201
Senior Vice President of Drug Discovery and Early Development at Novartis from 1996 to 20091
Director at DNAX Research Institute from 1988 to 19961
Director at Schering-Plough Research Institute from 1985 to 19881

Education

Jan de Vries holds a Doctor of Philosophy (PhD) in Immunology from the University of Amsterdam.1

Expertise

With his extensive background in biotechnology and pharmaceuticals, Jan de Vries has significant experience in drug discovery, early development, and leadership roles in the life sciences industry. His career trajectory shows a strong focus on innovative therapeutics and biotechnology companies.

Experience

Co-founder, Consultant, Board observer at Tr1X Bio (May 2023 - Present)

Co-founder and Chief Executive Officer at Tr1X (Jul 2019 - May 2023) Chairman at Cassiopea SpA (Jul 2015 - May 2023), AIMM Therapeutics (Jan 2018 - Dec 2020) CEO at AIMM Therapeutics (Jan 2012 - Dec 2017) Senior Vice President at Novartis (1996 - 2009) Director at DNAX Research Institute (Oct 1988 - Dec 1996), Schering-Plough Research Institute (1985 - 1988)